Location History:
- Cologne, DE (1981)
- Bergheim-Glessen, DE (1984 - 1987)
- Glessen, DE (1986 - 1987)
Company Filing History:
Years Active: 1981-1987
Title: The Innovative Mind of Ille-Stephanie Doppelfeld
Introduction
Ille-Stephanie Doppelfeld, an accomplished inventor based in Bergheim-Glessen, Germany, holds an impressive portfolio of seven patents. Her work predominantly focuses on pharmaceutical innovations, particularly in treating cardiovascular diseases and associated illnesses. Doppelfeld’s contributions are significant, pushing the boundaries of current medical treatments and providing hope for patients with heart conditions.
Latest Patents
Among her latest patents are innovative compounds that showcase her specialization in medicinal chemistry. One notable patent involves "Imidazole group containing 2(1H)-pyridones and method for treating heart." This invention targets new chemical structures that aim to treat congestive heart failure effectively. Another significant patent, "Imidazolylalkylthienyl tetrahydropyridazines and processes for their use," details new imidazolylalkylthienyltetrahydropyridazines designed for addressing cardiovascular and thromboembolic diseases in humans. These patents represent a critical advancement in therapeutic methods and showcase her inventive spirit.
Career Highlights
Doppelfeld works for A. Nattermann & Cie GmbH, a company well-regarded for its contributions to the pharmaceutical industry. Her tenure there reflects her commitment to innovation and her expertise in developing novel treatments. Throughout her career, Doppelfeld has become a notable figure in her field, recognized for her dedication and successful patent applications that bring new solutions to medical challenges.
Collaborations
Throughout her journey, Doppelfeld has collaborated with esteemed colleagues, including Gerrit Prop and Gerd Hilboll. These partnerships have fostered an environment of innovation and creativity, allowing for the exchange of ideas and the development of groundbreaking concepts in pharmaceutical research. Such collaborations are essential in driving forward the complex landscape of medical inventions.
Conclusion
Ille-Stephanie Doppelfeld stands out as a pivotal inventor in the field of cardiovascular treatment. Her seven patents illustrate her innovative approach and commitment to improving patient outcomes. As she continues her work at A. Nattermann & Cie GmbH, the medical community looks forward to her future contributions, which promise to lead to novel solutions in healthcare.